Formed in 1996, the Angels + Life.Sci Investors Network is organized under NJAngels.net. We are a manager-led, loosely organized network of investors and accredited Angels, Coaches, and Experts who Sponsor world class Entrepreneurs University programs www.EntreUniv.org 2019 calendar below.
This non-profit supports qualified Entrepreneurial CEOs to help them prepare internal Due Diligence, external Due Diligence and then properly, safely, & swiftly raise capital in select markets where professional investors make decisions.
Our colleagues have deep experience and technical domain expertise in all of the Life Sciences disciplines in which we’re involved, generally known as:
NanoBio Tools, Materials, + Devices:
2018 focus: TeleDiagnostics, Augmented Healthcare & Remote Patient
2017 focus: Automation and Robotics, & advanced Chemistry for Drug
2016 focus: Preventing Blindness w/ first instrument to treat Dry-Age Macular
Degeneration & a Medical Food for both Dry-AMD and Glaucoma
2015 focus: Protecting Wounded Warriors, Farmers, and our Food Supply.
We are keen on CEOs who are focused on improving Patient-outcomes and developing better, faster, less invasive, less painful, and less expensive healthcare solutions by discovering new technologies to commercialize:
· Drug Discovery, Genomic Diagnostics, advanced Imaging,
· RegenMedicines, Wound Healing, Stem Cell therapies,
Any Tools, Materials & Devices to equipment and protect:
· First Responders, Surgeons, Nurses, or Wounded Warriors.
· Protecting Food, Farmers, and Forests
Current portfolio available to Angels, email: DanConley@NJAngels.net
ANGELS, COACHES & EXPERTS convene monthly for Entrepreneurs University programs to help Entrepreneurial CEOs learn Best Practices in starting, capitalizing and growing their technology-based enterprise:
by helping them
Deconstruct + Reconstruct Their Business Plan + Pitch.
We review CEO’s Business Plans, often via webex, video or FreeConfCall-in.
Our next major NJAngels program, by invitation only, at Fiddler’s Elbow Country Club is:
Best of the Best CEOs: Bake-off for the Money Wed.25 July ’18
BEST of BEST CEOs: Bake-off For the Money
2017. Indigo Biosciences profitably sells Nuclear Receptor test kits and services to Drug Discovery Researchers at top Pharma & Biotechs Fred Marroni, CEO
2016. ThriveBio provides Robotics and Automation for Stem Cell Researchers producing Cell-based therapeutics. Tom Farb-Horch CEO
2016. Myomo, Inc. “My Own Motion” makes exoskeleton braces for upper limbs to restore motion for Patients w/ paralysis due to stroke, brain injury, neurological conditions.
Paul Gudonis, CEO
2016. Guardion Health Sciences, Inc. Optometrist measures macular’s pigment w/ non-invasive Densiometer, then prescribes medical food LumegA-Z to restore density of macular’s pigment & staves-off or avoids precursors to Dry-AMD. Plus Glaucoma formula. Michael Favish, CEO
2014. LumiThera makes non-invasive ! instrument to treat Dry Age-related Macular Degeneration using low-level LED laser light at specific multi-frequencies which reduce Drusen build-up: Patient proof! Closed $3.0M Pref-A seed round. Raised $5.0M B-round. CE Mark & approval by Health Canada. Commercial units 2H’17. PhotoBioModulation to become first therapy for Dry-AMD. Clark E. Tedford, PhD CEO.
2012 ZipStitchClips improve laparoscopic Surgical Closures post-hysterectomy for Gynecological Surgeons to more swiftly & securely close internal surgeries in lieu of tying suture knots after a long sometimes complicated procedure. ZipStitchClips are strong, & made of approved bio-resorbable polymer. They spread their gripping force across much wider area than needle-based suturing. ZSX Medical Dan Mazzucco, PhD, CEO
2010. PluroGen makes PluroGel, which delivers antibiotics, and accelerates wound healing by debriding & protecting wounds. It makes bandage changing easier and less painful for Patients. PluroGel-SSD in eight European countries during 2011-12. Under IND process for FDA trials w/ Wounded Warriors using PluroGel-triple antibiotic PNN which Pentagon helped fund two years. Neal Koller, CEO.
2009. Immunomix LAMP vaccines retrain Patients’ immune system: battle & win vs allergies & glioblastoma cancer. Big Pharma licenses LAMP allergy platform to validate multi-year exam into LAMP applications – initially dosing Patients for tree & grass Allergies. Bill Hearl, PhD, CEO.
2008. Sword Diagnostics’s ultra-sensitive chemistry reagent detects tiniest diseased cell or cancer cell via blood draw test. World leader Tecan Instruments paid SwordDx for North American roll-out using chemistry in their instruments for many Reference Customers. Dave Dingott, CEO.
ANGELS + LIFE SCI INVESTORS NETWORK
Co-sponsor programs on First Mondays at the
COMMERCIALIZATION CENTER FOR INNOVATIVE TECHNOLOGIES
Produced by Dan Conley, OnCallCFO for Fundable Teams,
Angels Forums DanConley@NJAngels.net VenturEvaluations and Due Diligence are performed by network of expert Sponsors of Entrepreneurs University programs www.EntreUniv.org a 34-year young, non-profit For Purpose training and educational institute which helps Entrepreneurs prepare to raise outside capital.
NJAngels’ VenturEvaluations help commercialize science
by helping Entrepreneurial CEOs organize their
unfair commercial & technological advantages into
a Fundable Business Plan based on Know-How using:
NanoBio Tools, Materials, + Devices
Companion Diagnostics for Personalized Medicines,
Vaccines, Regen+NeuroMedicine Discovery Tools,
Drug Delivery, Patient Adherence & Compliance,
Anything for Wounded Warriors, First Responders
Dx & Tx imaging niches, InfoTech to Fix Healthcare.
COMMERCIALIZATION CENTER FOR INNOVATIVE TECHNOLOGIES
# 675 Rte 1s, No. Brunswick, NJ 08902.
CEO FORUMS are 20-Minute Forums to help CEOs make Ten-Minute
Corporate Overview Presentations: $40. + $2. PayPal fee.
Technical Programs help CEOs learn: HOW TO VENTURE
pre-register: DanConley@NJAngels.net or via www.EntreUniv.org
OnCallCFO for Fundable Teams
Managing Director, Angels + Life.Sci Investors Networks
Entrepreneurs University programs: www.EntreUniv.org